Connection
Satish Garg to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Satish Garg has written about Dipeptidyl-Peptidase IV Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.914 |
|
|
|
-
Garg SK, Michels AW, Shah VN. Use of non-insulin therapies for type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):901-8.
Score: 0.418
-
Garg SK, Moser EG, Bode BW, Klaff LJ, Hiatt WR, Beatson C, Snell-Bergeon JK. Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocr Pract. 2013 Jan-Feb; 19(1):19-28.
Score: 0.396
-
Garg SK. New therapies for diabetes management. Diabetes Technol Ther. 2013 Feb; 15 Suppl 1:S126-35.
Score: 0.100